Literature DB >> 22130726

[Punctate inner choroidopathy - Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up control].

S Weiss1, R Winter, M W Meyer.   

Abstract

Punctate inner choroidopathy (PIC) is a rare disease which seems to have an inflammatory origin. Treatment is symptom-oriented and the development of choroidal neovascularization (CNV). If CNV is present the trend is towards the use of anti-VEGF (vascular endothelial growth factor) therapy. Oral therapy with steroids should be initially attempted.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22130726     DOI： 10.1007/s00347-011-2449-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  15 in total

1.  Recurrent multifocal choroiditis.

Authors:  C M Morgan; H Schatz
Journal:  Ophthalmology       Date:  1986-09       Impact factor: 12.079

2.  Indocyanine green angiography of multifocal choroiditis.

Authors:  J S Slakter; A Giovannini; L A Yannuzzi; B Scassellati-Sforzolini; D R Guyer; J A Sorenson; R F Spaide; D Orlock
Journal:  Ophthalmology       Date:  1997-11       Impact factor: 12.079

3.  Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.

Authors:  Maurizio Battaglia Parodi; Pierluigi Iacono; Dimitrios Stelyos Kontadakis; Ilaria Zucchiatti; Maria Lucia Cascavilla; Francesco Bandello
Journal:  Arch Ophthalmol       Date:  2010-09

4.  Punctate inner choroidopathy: a survey analysis of 77 persons.

Authors:  Adam T Gerstenblith; Jennifer E Thorne; Lucia Sobrin; Diana V Do; Syed Mahmood Shah; C Stephen Foster; Douglas A Jabs; Quan Dong Nguyen
Journal:  Ophthalmology       Date:  2007-04-16       Impact factor: 12.079

5.  Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings.

Authors:  T W Olsen; A Capone; P Sternberg; H E Grossniklaus; D F Martin; T M Aaberg
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

6.  The use of corticosteroids for choroidal neovascularisation in young patients.

Authors:  C J Flaxel; S L Owens; B Mulholland; S D Schwartz; Z J Gregor
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

7.  Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy.

Authors:  Richard F Spaide; K Bailey Freund; Jason Slakter; John Sorenson; Lawrence A Yannuzzi; Yale Fisher
Journal:  Retina       Date:  2002-10       Impact factor: 4.256

Review 8.  [White dot syndrome].

Authors:  W Göbel
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

9.  Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome.

Authors:  J Brown; J C Folk; C V Reddy; A E Kimura
Journal:  Ophthalmology       Date:  1996-07       Impact factor: 12.079

10.  Pathological findings of multifocal choroiditis with panuveitis and punctate inner choroidopathy.

Authors:  Hiroyuki Shimada; Mitsuko Yuzawa; Tokihito Hirose; Hiroyuki Nakashizuka; Takayuki Hattori; Yoko Kazato
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447
View more
  1 in total

1.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.